Brian Dorsey - Net Worth and Insider Trading
Brian Dorsey Net Worth
The estimated net worth of Brian Dorsey is at least $90,300 dollars as of 2024-11-05. Brian Dorsey is the COO of ARS Pharmaceuticals Inc and owns about 6,024 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $90,300. Details can be seen in Brian Dorsey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Dorsey has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Dorsey
Brian Dorsey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Dorsey owns 4 companies in total, including Seelos Therapeutics Inc (SEEL) , Pernix Therapeutics Holdings Inc (PTXTQ) , and Silverback Therapeutics Inc (SBTX) among others .
Click here to see the complete history of Brian Dorsey’s form 4 insider trades.
Insider Ownership Summary of Brian Dorsey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SEEL | Seelos Therapeutics Inc | 2014-12-01 | Chief Development Officer |
| PTXTQ | Pernix Therapeutics Holdings Inc | 2014-10-10 | SVP Research |
| SBTX | Silverback Therapeutics Inc | 2022-12-06 | Chief Operating Officer |
 | | 2024-08-20 | Chief Operating Officer |
Brian Dorsey Latest Holdings Summary
Brian Dorsey currently owns a total of 1 stock. Brian Dorsey owns 6,024 shares of ARS Pharmaceuticals Inc (SPRY) as of August 20, 2024, with a value of $90,300.
Latest Holdings of Brian Dorsey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals Inc | 2024-08-20 | 6,024 | 14.99 | 90,300 |
Holding Weightings of Brian Dorsey
Brian Dorsey Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Dorsey has made a total of 2 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 50,000 shares on August 20, 2024, which brought Brian Dorsey around $750,000.
Insider Trading History of Brian Dorsey
- 1
Brian Dorsey Trading Performance
Brian Dorsey Ownership Network
Ownership Network List of Brian Dorsey
Ownership Network Relation of Brian Dorsey
Brian Dorsey Owned Company Details
What does Seelos Therapeutics Inc do?
Who are the key executives at Seelos Therapeutics Inc?
Brian Dorsey is the Chief Development Officer of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and SVP & Chief Business Officer Neil Morton .
Seelos Therapeutics Inc (SEEL) Insider Trades Summary
Over the past 18 months, Brian Dorsey made no insider transaction in Seelos Therapeutics Inc (SEEL). Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .
In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.
Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seelos Therapeutics Inc Insider Transactions
Brian Dorsey Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Dorsey. You might contact Brian Dorsey via mailing address: C/o Somaxon Pharmaceuticals, Inc., 10935 Vista Sorrento Parkway, Suite 250, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
